Partner Spotlight: SeedSprint
SeedSprint is the innovation ecosystem that connects emerging technologies with industry partners. The platform is free for emerging technology companies and research institutions and available to industry at a flat...
VIC 2020 Mid-Year Update
So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded...
Vixiar: Solving a Big Problem With a Small Device
Last month at Vixiar Medical, we reached a major milestone on the road to commercial launch of our Indicor™ device with the submission of our 510(k) to the FDA. We hope to have clearance to market our product in the...
Portfolio Diversification in Times of Market Volatility
Update It is now March 2021, and nine months after writing this piece below, saying that things have evolved would be an understatement. Focusing on the positive progress made to date, we have three approved vaccines in...
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
As the recent pandemic has made all too clear, organizations need to proactively prepare for the realities of a dispersed workforce, which is especially true for investor groups such as venture capital and private...
Neurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant
AURORA, CO - Neurexis Therapeutics, Inc. announced today that it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries Accelerator...
Zebra Analytix Awarded NIH Funding to Improve Workplace Safety
FAYETTEVILLE, AR - Zebra Analytix—a VIC Technology Venture Development portfolio company—announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institute of...
VIC Fellow Spotlight: Dr. Natalie Gassman
The VIC Fellows Program was created in late 2019 as a mechanism for individuals with specific expertise to learn about and be involved in identifying and evaluating promising life science innovations from universities,...
Why VIC Sometimes Steps Outside Its Life Science Focus
VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...
CardioWise Makes FDA Submission With Request for Expedited Approval for COVID-19
This month, CardioWise filed a 510(k) Application for its machine learning-based heart health analysis software known as SQuEEZTM. The software, combined with cardiac computerized tomography (CT) imaging, has the...
